Clinical trials
Bronchiolitis Obliterans Syndrome trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 8 |
| AstraZeneca | 3 |
| I.M. Sechenov First Moscow State Medical University | 2 |
| Pfizer | 2 |
| R-Pharm | 2 |
| St. Petersburg State Pavlov Medical University | 2 |
| Botkin Hospital | 1 |
| Bristol-Myers Squibb | 1 |
| Hoffmann-La Roche | 1 |
| Incyte Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bronchiolitis Obliterans Syndrome | 25 |
| Graft vs Host Disease | 5 |
| Lymphoma, Follicular | 4 |
| Leukemia | 3 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
| Pulmonary Disease, Chronic Obstructive | 3 |
| Bronchitis | 2 |
| Chronic Urticaria | 2 |
| Emphysema | 2 |
| Gingivitis | 2 |
Trials
Showing 26 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.